DISABILITY-ADJUSTED-LIFE-YEARS (DALYS) LOSS IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS-
Author(s)
Darba J1, Kaskens L2, Perez-Alvarez N2, Palacios S3, Neyro JL4, Rejas J51Universitat de Barcelona, Barcelona, Spain, 2BCN Health, Barcelona, Spain, 3Instituto Palacios de Salud y Medicina de la Mujer, Madrid, Spain, 4Hospital Universitario Cruces, Baracaldo (Vizcaya), Spain, 5Pfizer España, Alcobendas/Madrid, Spain
OBJECTIVES: To estimate the disability-adjusted life years (DALYs) lost in a nationwide representative sample of postmenopausal women with osteoporosis. Effect of previous bone fracture and type of drug-based therapy of osteoporosis were also explored. METHODS: DALYs were estimated based on patients’ clinical characteristics and Health-Related Quality-of-Life (HRQoL) data from a cross-sectional, epidemiological one-visit study (the GINERISK study). The study enrolled postmenopausal women (at least 12-month after last menstrual period) with osteoporosis, above 18-years old, who were attending outpatient clinics of Gynecology in Spain. Socio-demographics, bone densitometry (BD) and HRQoL were recorded. HRQoL was assessed using the generic SF-12v2 questionnaire, which was used to derive disutility values. Mortality rates were extracted from the Spanish national statistics database. DALY´s were calculated according to Fox-Rushby and Hanson (2001) and ANCOVA models, adjusted for age, BD, previous osteoporotic bone fractures (BF), treatment with calcium or calcium+vitamin D, exercise and number of risk factors for osteoporosis, were used for comparative purposes. RESULTS: DALYs could be computed in 2,782 (67%) out of 4,157 postmenopausal women, with a mean (95% CI) age of 61.0 (60.7-61.2) years. Mean overall undiscounted DALY´s lost per women were 6.1 (5.9-6.2), with a significantly higher loss in women with previous BF; 7.8 (7.2-8.4) in comparison with women without BF [5.8 (5.6-6.0)] or osteoporotics with a BD >-2.5 T-score after receiving a drug-based therapy [6.2 (5.8-6.5)]; F=27.0 (P<0.01). A model explaining the variation in the levels of health was found which included the use of a SERM-based therapy, age, previous osteoporotic BF and the number of risk factors for osteoporosis as significant predictors (P <0.05). CONCLUSIONS: DALY´s loss was considerable amongst postmenopausal women with osteoporosis. The use of a SERM, not having previous osteoporotic bone fracture, having less osteoporotics risk factors and being older showed to be linked to less DALY´s lost.
Conference/Value in Health Info
2012-11, ISPOR Europe 2012, Berlin, Germany
Value in Health, Vol. 15, No. 7 (November 2012)
Code
PIH35
Topic
Patient-Centered Research
Topic Subcategory
Patient-reported Outcomes & Quality of Life Outcomes
Disease
Musculoskeletal Disorders, Reproductive and Sexual Health